Defendant Name: Sientra, Inc.

Defendant Type: Public Company

Document Reference: LR-24275

Document Details

Legal Case Name In the Matter of Sientra, Inc.
Document Name SEC Charges Medical Aesthetics Company and Its Former CEO with Misleading Investors in a $60 Million Stock Offering
Document Date 19-Sep-2018
Document Format Administrative Proceeding
File Number 3-18795
Allegation Type Issuer Reporting and Disclosure
Document Summary On September 19, 2018, the SEC issued a litigation release regarding charges against Sientra, Inc., stating: "The Security and Exchange Commission today charged Sientra, Inc., a California-based medical aesthetics company, and its former CEO, Hani Zeini, with concealing damaging news about the company's sole-source manufacturer before it closed a $60 million stock offering in 2015. The company agreed to settle the SEC's charges."

Disgorgement & Penalty Information

Resolutions
Cooperation Before the Resolution
Self Reporting to SEC

Related Documents:

33-10555 19-Sep-2018 Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 8A of the Securities Act of 1933 and Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
On September 19, 2018, the SEC issued an order against Sientra, Inc., stating: "These proceedings arise from the fraudulent concealment of damaging news about Sientra's former sole-source contract manufacturer before it closed a more than $60 million follow-on offering in September 2015."

Related Actions:

SEC v. Hani Zeini
Hani Zeini